SRSF2-P95H降低造血细胞JAK/STAT信号并延缓小鼠骨髓纤维化发展
在可诱导敲入小鼠模型中,Srsf2P95H意外延缓了Jak2V617F诱导的骨髓纤维化并降低血清TGFβ1水平,同时降低移植的Jak2V617F造血干细胞竞争力但防止其耗竭。RNA测序显示两突变联合增加剪接事件,Srsf2P95H促进Jak2外显子14跳跃,产生截短失活JAK2蛋白,该事件在JAK2V617F与SRSF2P95共突变患者中可检测到。
要点
- Srsf2P95H延缓Jak2V617F诱导的小鼠骨髓纤维化并降低血清TGFβ1水平。
- Srsf2P95H降低移植Jak2V617F造血干细胞竞争力但防止其耗竭。
- Srsf2P95H促进Jak2外显子14跳跃,产生截短失活JAK2蛋白。
核心结论
- Srsf2P95H通过促进Jak2外显子14跳跃降低JAK/STAT信号,从而延缓小鼠骨髓纤维化发展。
研究设计与样本
- 研究使用可诱导敲入小鼠模型,在干细胞白血病(Scl)基因启动子控制下表达Srsf2P95H和Jak2V617F突变体,并进行移植实验。
主要发现
- 移植实验中,Srsf2P95H意外延缓Jak2V617F诱导的骨髓纤维化并降低血清TGFβ1水平。
- Srsf2P95H降低移植的Jak2V617F造血干细胞竞争力,同时防止其耗竭。
- 分选巨核细胞的RNA测序显示,两突变联合时剪接事件数量增加。
- Srsf2P95H促进Jak2外显子14跳跃,该事件在JAK2V617F与SRSF2P95共突变患者中可检测到,并产生截短失活JAK2蛋白。
- Srsf2P95H延缓血小板生成素受体激动剂罗米司亭在Jak2野生型动物中诱导的骨髓纤维化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Heterozygous mutation targeting proline 95 in Serine/Arginine-rich Splicing Factor 2 (SRSF2) is associated with V617F mutation in Janus Activated Kinase 2 (JAK2) in some myeloproliferative neoplasms (MPNs), most commonly primary myelofibrosis. To explore the interaction of Srsf2P95H with Jak2V617F, we generated Cre-inducible knock-in mice expressing these mutants under control of the stem cell leukemia (Scl) gene promoter. In transplantation experiments, Srsf2P95H unexpectedly delayed myelofibrosis induced by Jak2V617F and decreased TGFβ1 serum level. Srsf2P95H reduced the competitiveness of transplanted Jak2V617F hematopoietic stem cells while preventing their exhaustion. RNA sequencing of sorted megakaryocytes identified an increased number of splicing events when the two mutations were combined. Focusing on JAK/STAT pathway, Jak2 exon 14 skipping was promoted by Srsf2P95H, an event detected in patients with JAK2V617F and SRSF2P95 co-mutation. The skipping event generates a truncated inactive JAK2 protein. Accordingly, Srsf2P95H delays myelofibrosis induced by the thrombopoietin receptor agonist Romiplostim in Jak2 wild-type animals. These results unveil JAK2 exon 14 skipping promotion as a strategy to reduce JAK/STAT signaling in pathological conditions.
引用
- Willekens C, Laplane L, Dagher T, et al. SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice. Leukemia. 2023. PMID: 37100881. doi:10.1038/s41375-023-01878-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。